NYT: Johnson & Johnson's COVID-19 booster shot provides strong protection against Omicron
The study, found that two shots of the vaccine reduced the risk of hospitalization from Omicron by about 85%.
•
Dec 30, 2021, 10:58 AM
•
Updated 939 days ago
Share:
More Stories
Hometown Heroes in Connecticut
100ds ago
Nobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
298ds ago0:29
Connecticut health commissioner fired during COVID settles with state; dismissal now a resignation
304ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
310ds ago2:00
Should you get a COVID booster? Hartford Healthcare doctor says wait
331ds ago0:22
Nearly 200 Stamford small businesses to receive COVID-19 relief grants
350ds agoHometown Heroes in Connecticut
100ds agoNobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
298ds ago0:29
Connecticut health commissioner fired during COVID settles with state; dismissal now a resignation
304ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
310ds ago2:00
Should you get a COVID booster? Hartford Healthcare doctor says wait
331ds ago0:22
Nearly 200 Stamford small businesses to receive COVID-19 relief grants
350ds agoJohnson & Johnson's COVID-19 booster shot is said to provide strong protection against the Omicron variant, and greatly reduces the risk of hospitalization, according to a clinical trial in South Africa, the New York Times says.
The study, found that two shots of the vaccine reduced the risk of hospitalization from Omicron by about 85%.
